No valuation for Biovision Biomedical Technology is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($42.3M) and the funding record below are the closest available signals.
- ·Watch Biovision Biomedical Technology: the Monday email on marks, rounds and moves
Biovision Biomedical Technology funding history
No funding rounds for Biovision Biomedical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
How Biovision Biomedical Technology's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Biovision Biomedical Technology, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Biovision Biomedical Technology
- How much has Biovision Biomedical Technology raised?
- Biovision Biomedical Technology has raised $42.3M in total funding across its recorded rounds.